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Introduction
Epilepsy, common neurological disorder affecting approximately 1-2% of the population worldwide (Hauser and Hesdorffer, 1990; McNamara, 1999) , is characterized by the occurrence of spontaneous recurrent epileptiform discharges (SREDs) in populations of neurons. Acquired epilepsy (AE) is caused by a known brain injury, such as status epilepticus (SE), stroke, or traumatic brain injury that induces long-lasting plasticity changes in previously normal brain tissue and leads to the development of SREDs (Hauser and Hesdorffer, 1990) . Epileptogenesis is the process responsible for transforming normal brain tissue into the epileptic phenotype, manifesting the occurrence of seizures or SREDs (Shin and McNamara, 1994; DeLorenzo et al., 1998; Delorenzo et al., 2005) . Although considerable research is being conducted on long-term changes associated with epileptogenesis, the exact cellular and molecular mechanisms involved in epileptogenesis are still not completely understood (Shin and McNamara, 1994; Delorenzo et al., 2005) . Therefore, studies elucidating the underlying mechanisms mediating the plasticity changes associated with epileptogenesis are crucial to advancing both the treatment and prevention of epilepsy.
It has been suggested that chronic elevations in intracellular Ca 2+ ([Ca 2+ ] i ) and alterations in Ca 2+ homeostatic mechanisms in epileptic neurons play a role in the induction and maintenance of the epileptic phenotype (DeLorenzo et al., 1998; Raza et al., 2001; Raza et al., 2004; Delorenzo et al., 2005) . Calcium is an important second messenger involved in diverse cellular events, such as membrane excitability and synaptic activity (Delorenzo et al., 2005) . neurons provides a novel model for studying epileptiform activity.
Methods
Hippocampal Neuronal Culture
Primary hippocampal cultures were prepared as previously described by our laboratory (Sombati and Delorenzo, 1995) . Briefly, hippocampal cells were isolated from 2-day postnatal Sprague-Dawley rats (Harlan, Indianapolis, IN) and plated at a density of 2.4 x 10 4 cells/cm JPET# 110403 recover in oligonucleotide-free medium. After full recovery of CaMK-II activity, cultures were utilized for [Ca 2+ ] i measurements.
Measurement of CaMK-II activity
CaMK-II activity was determined measuring CaMK-II-dependent substrate phosphorylation of the synthetic peptide Syntide II (Sigma, St. Louis, MO) following the methods of Churn (Churn, 1995) . Phosphorylation reaction solutions contained 41 µg of protein, 60 µM Syntide II, 10 mM MgCl 2 , 7 µM [γ-32 P]ATP, 10 mM PIPES (pH 7.4), ± 5 µM CaCl 2 and ± 1 µg calmodulin. Standard reactions were performed in a shaking water bath at 30 °C. The phosphorylation reactions were initiated by adding Ca 2+ , continued for 1 min, and stopped by adding 20 µM EDTA. 10 µL aliquots of assay solution were blotted onto P-81 phosphocellulose filter paper (Whatman). Each reaction was quantitated in triplicate. The filter paper was then washed three times in 50 mM phosphoric acid, rinsed with acetone, and allowed to air dry.
Radioactive phosphate was then quantitated by scintillation counting (Churn, 1995) .
Immunocytochemical staining of α CaMK-II
After briefly washing in phosphate buffered saline (PBS), neuronal cultures were fixed in 4% paraformaldehyde in PBS for 10 minutes followed by 3 x 5 min wash in PBS. Fixed cultures were blocked and permeabilized in SuperBlock® blocking buffer (Pierce, Rockford, IL) containing 0.2% Triton X-100 for 60 min at room temperature. Cells were then incubated with a mouse monoclonal antibody to the CaMK-II α subunit (10 µ g/ml, clone 6G9; Biomol, Plymouth JPET# 110403
Intracellular free calcium measurements
Intracellular free Ca 2+ measurements were carried out using previously established procedures (Pal et al., 1999; Pal et al., 2001; Raza et al., 2001; Sun et al., 2004 on an Olympus IX-70 inverted microscope fitted with a 20X fluorite water immersion objective and coupled to an ultra high-speed fluorescence imaging system (Olympus America/Perkin Elmer). The fluorescence excitation source was a 75W Xenon arc lamp (Olympus America).
Neutral density filters of variable opacities were used to attenuate unwanted excitation.
Alternating excitation wavelengths of 340 nm and 380 nm were generated using a Lambda 10-2 filter wheel (Sutter Instruments Co., Novato CA) and 510 nm emissions were acquired using a Fura filter cube (Olympus America) with a dichroic at 400 nm. Alternating emissions from 340 nm and 380 nm excitation were captured with an ORCA-ER high-speed digital CCD camera (Hamamatsu Photonics K.K., Japan). Image acquisition and processing was computer controlled using the UltraVIEW™ Imaging system software v5.2 (Perkin Elmer). Using the image analysis software, a region of interest was selected for each pyramidal-shaped neuron in the field and intracellular free Ca 2+ levels were presented as an absolute ratio value of 340/380 excitationemissions. To calculate 340/380 ratio values, image pairs at each wavelength were captured and digitized at varying intervals and the images at each wavelength were averaged over four frames. (Pal et al., 1999; Pal et al., 2000; Raza et al., 2001; Sun et al., 2004 (Pal et al., 2000; Raza et al., 2001 (Pal et al., 2001 ). An in vitro calcium calibration curve was constructed for each indicator and used to convert fluorescent ratios to [Ca 2+ ] i concentrations using ionomycin (10µM) and prepared calibration buffers (Invitrogen, Carlsbad, CA). [Ca 2+ ] i concentrations were calculated from the background corrected 340/380 ratios using the following equation (Grynkiewicz et al., 1985) :
where R is the 340/380 ratio at any time; R max is the maximum measured ratio in saturating Ca 2+ solution (39µM free Ca 2+ ); R min is the minimal measured ratio Ca 2+ free solution; S f2 is the absolute value of the corrected 380-nm signal at R min ; S b2 is the absolute value of the corrected 380-nm signal at R max ; and the K d values used were 224 nM and 20 µM for Fura-2 and Fura-FF respectively (Pal et al., 2001; Sun et al., 2004 (Pal et al., 2000; Raza et al., 2001) . Although the peak [Ca 2+ ] i concentration varied between Fura-2 and Fura-FF as previously observed (Pal et al., 2000) , the ability of the indicators to reflect the neurons Ca 2+ buffering capability was similar. Although Fura-2 gave a lower absolute calcium concentration upon calibration, the shapes of its decay curves were almost identical to those of Fura-FF. 
Data Analysis
Results
Suppression of CaMK-II activity and protein expression in hippocampal neurons in culture.
These studies were initiated to evaluate whether the decreased activity and expression of CaMK-II caused by antisense oligonucleotide suppression specific for the α subunit of CaMK-II were reversible. Hippocampal neurons in culture were exposed to either missense or antisense oligonucleotides specific for the α subunit of CaMK-II. CaMK-II-dependent substrate phosphorylation of the synthetic peptide Syntide II was carried out to evaluate the activity of CaMK-II following oligonucleotide treatment (Fig1A). Immunocytochemical staining was performed to determine the localization of the α subunit of CaMK-II in cultures treated with missense or antisense oligonucleotides ( Fig 1B) . Antisense oligonucleotide treatment significantly decreased CaMK-II activity and protein expression in comparison to control and missense-treated neurons ( Fig 1A and B) . Removal of the antisense oligonucleotide treatment followed by a 3-day recovery period resulted in a restoration of CaMK-II activity and protein expression to missense control levels (Fig 1A and B: bottom panel) , demonstrating that the antisense oligonucleotide suppression CaMK-II was reversible.
Suppression of CaMK-II activity correlates with the development of epileptiform activity.
Whole-cell current-clamp recordings were performed on pyramidal neurons from control, missense-treated, antisense-treated, and antisense-recovered cultures (Fig 2) . Recordings from missense-treated cultures showed the absence of SREDs and manifested similar intrinsic baseline activity as seen in control cultures (Fig 2A and B) . Antisense oligonucleotide suppression of CaMK-II resulted in the expression of SREDs in hippocampal neurons ( Fig 2C) . Expansion of A and B), SREDs were no longer observed and neuronal electrophysiological activity returned to control levels ( Fig 2D) . These results demonstrate that recovery from antisense-oligonucleotide treatment restored CaMK-II activity and completely abolished SREDs, strongly indicating a causal relationship between CaMK-II suppression and the development of SREDs.
Suppression of CaMK-II activity results in elevation of basal [Ca
2+
] i . Figure   3A ).
This article has not been copyedited and formatted. The final version may differ from this version. ] i levels was reversible, treatment with antisense oligonucleotide to α CaMK-II was discontinued and neurons were allowed 3 days to recover. As previously shown, SREDs were no longer observed and the activity and protein expression of CaMK-II were restored to normal levels following recovery ( Fig. 1 and 2 between missense-treated and antisense-treated neurons (Fig 5C and D) . Individual curves, normalized as percent of Ca 2+ load were averaged and compared using the RM ANOVA (Sun et al., 2004) . By 30 minutes post-glutamate, missense-treated neurons recovered to within 10% of their Ca 2+ load (8.3% ± 1.9% for Fura-2 and 6.7% ± 3.3% for Fura-FF). Antisense-treated neurons recovered to 45% of their Ca 2+ load (44.6% ± 5.0% for Fura-2 and 45.7% ± 14.3% for Fura-FF), which is significantly elevated over missense-treated neurons (p<0.001).
This article has not been copyedited and formatted. The final version may differ from this version. load was produced by brief exposure to glutamate (50 µM, 2 min) (Fig. 7) . In order to compare the Ca 2+ decay curves of missense-treated, antisense-treated and antisense-recovered neurons, the ratio values were normalized to percent of Ca 2+ load as previously described. As previously reported, missense-treated neurons declined to 8.3% of their Ca 2+ load whereas antisenserecovered neurons only recovered to 44.6% of their Ca 2+ load during the 30 min of recording.
Antisense-recovered neurons recovered to 13.7% ± 2.3% of their Ca 2+ load, which is This article has not been copyedited and formatted. The final version may differ from this version. neurons, similar to findings observed in hippocampal neuronal culture models of both SE and stroke-induced AE (Pal et al., 1999; Sun et al., 2004 A decrease in function of CaMK-II has been shown to occur in a number of models of epilepsy (Bronstein et al., 1993; Butler et al., 1995; Churn et al., 2000a; Churn et al., 2000b) .
However, this is the first study that shows a direct relationship between a specific suppression of CaMK-II activity and a loss in the ability of neurons to maintain Ca 2+ homeostatic mechanisms This article has not been copyedited and formatted. The final version may differ from this version. Calcium plays a pivotal role in normal neuronal function (Llinas et al., 1992; Berridge, 1998 ] i is maintained around 100 nM (Mody and MacDonald, 1995 Raza et al., 2004) , and even in the chronic spontaneous recurrent seizures (epilepsy) phases of AE (Pal et al., 2000; Pal et al., 2001; Raza et al., 2001; Raza et al., 2004 (Kunz et al., 1999) and efflux via the plasma membrane Na + /Ca 2+ exchanger (Ryan, 1999) . In addition, a number [Ca 2+ ] i buffering systems which include the binding proteins calbindin, calretinin and parvalbumin (Nagerl et al., 2000) ] i and the impaired ability to buffer a Ca 2+ load. These results are similar to previous observations of altered [Ca 2+ ] i in other models of epilepsy, including a low Mg 2+ -induced SE model of AE (Pal et al., 1999 ) and the stroke model of AE (Sun et al., 2004) . CaMK-II activity plays a role in maintaining Ca 2+ homeostasis in both skeletal and cardiac muscle, with a positive correlation between CaMK-II activity and SERCA activity. In these tissues, CaMK-II has been shown to regulate SERCA by two different mechanisms. One mechanisms involves CaMK-II phosphorylation of the SERCA accessory protein, phospholamban, which enhances the uptake of Ca 2+ by SERCA (Colyer, 1998). Although phospholamban is not present in neurons (Plessers et al., 1991) , there is evidence that a protein analogous to phospholamban exists in neurons and may be required for neuronal SERCA activity (Dou and Joseph, 1996) . Additionly, SERCA activity in skeletal muscle is increased by direct phosphorylation by CaMK-II (Xu et al., 1993) . This relationship has yet to be studied in neurons and could provide the link between decreased CaMK-II activity and altered Ca 2+ homeostasis in our model of epilepsy.
A better understanding of the molecular mechanisms that underlie the relationship between altered Ca 2+ dynamics and the induction and maintenance of AE is important for understanding the process of epileptogenesis (Delorenzo et al., 2005) . Although further studies are needed, it is apparent that elucidating the molecular basis contributing to altered Ca 
